Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
SODIUM CROMOGLICATE
Moorfields Eye Hospital NHS Foundation Trust
S01GX01
SODIUM CROMOGLICATE
2 %w/v
Eye Drops Solution
Product not subject to medical prescription
Other antiallergics
Authorised
2009-11-27
2 PACKAGE LEAFLET: INFORMATION FOR THE USER CATACROM 2 % W/V EYE DROPS, SOLUTION Sodium cromoglicate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. For brevity, this medicine will be referred to as Catacrom Eye Drops throughout this leaflet. Catacrom Eye Drops are available without prescription but you still need to take care to get the best results from them. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What Catacrom Eye Drops are and what they are used for 2. What you need to know before you use Catacrom Eye Drops 3. How to use Catacrom Eye Drops 4. Possible side effects 5. How to store Catacrom Eye Drops 6. Contents of the pack and other information 1. WHAT CATACROM EYE DROPS ARE AND WHAT THEY ARE USED FOR Catacrom Eye Drops are for the relief and treatment of allergic red, watery, itchy and puffy eyes caused by hayfever, house mites, and other causes of allergy such as pet hairs. Eye allergy can happen when sensitive eyes are exposed to these causes of allergy. Catacrom Eye Drops is a medicine which affects cells called mast cells. It prevents them from releasing chemical substances which cause symptoms such as the redness, watering, itching and puffiness of allergic reactions. These eye drops can be used by wearers of rigid or gas permeable contact lenses and can be used by people who are sensitive to preservatives in other kinds of eye drops. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE CATACROM EYE DROPS DO NOT USE CATACROM EYE DROPS: - if you are allergic to sodium cromoglicate or any of the other ingredients of t read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Catacrom 2% w/v eye drops, solution. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sodium cromoglicate 2.0% w/v. Each individual single-dose unit contains 6mg of sodium cromoglicate in 0.3ml of solution For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution (eye drops) Clear, colourless solution in a single-dose container. The eye drops are sterile and preservative free. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Catacrom 2% w/v eye drops are indicated for the relief and treatment of seasonal and perennial allergic conjunctivitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Topical ophthalmic use. Adults, children and the elderly: one or two drops into each eye four times per day, or as directed by the doctor. 4.3 CONTRAINDICATIONS Known hypersensitivity to sodium cromoglicate 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Catacrom 2% w/v eye drops are sterile, preservative free and presented in a single-use container which should be discarded after use. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION None known 4.6 FERTILITY, PREGNANCY AND LACTATION Catacrom 2% w/v eye drops should be used with caution in pregnancy, especially during the first trimester. Extensive experience with sodium cromoglicate suggests that there are no adverse effects on foetal development. Nevertheless, it should only be used in pregnancy where there is a clinical need. It is not known whether sodium cromoglicate is excreted in breast milk; however, on the basis of its physicochemical properties, it is considered unlikely. There is no evidence that the use of sodium cromoglicate has any undesirable effects on the baby. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ read_full_document